Search for: "MYLAN LABORATORIES LTD"
Results 41 - 60
of 116
Sort by Relevance
|
Sort by Date
21 Mar 2012, 11:32 am
The ruling, which was a victory for Mylan Inc.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
12 Oct 2011, 12:33 pm
In addition, the Court denied a petition for certiorari brought by generic drug manufacturer Mylan Laboratories, Inc. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
27 Aug 2011, 7:55 pm
Ltd. v. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc, Cephalon… [read post]
27 Jul 2011, 4:06 pm
Caraco :Defendants-Appellees Caraco Pharmaceutical Labora- tories, Ltd. and Sun Pharmaceutical Industries, Ltd. [read post]
27 Jun 2011, 8:41 am
Petitioners’ reply Amicus brief of Parents Television Council Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
24 Jun 2011, 3:25 pm
Certiorari stage documents:Opinion below (6th Circuit) Petition for certiorari Brief in opposition CVSG Information:Invited: February 28, 2011Filed: May 26, 2011 (Deny) Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
15 Jun 2011, 4:56 am
Mylan Inc. et al. [read post]
27 May 2011, 8:56 am
Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
28 Mar 2011, 7:32 am
EEOC (Granted )Docket: 10-553Issue(s): Whether the ministerial exception, which prohibits most employment-related lawsuits against religious organizations by employees performing religious functions, applies to a teacher at a religious elementary school who teaches the full secular curriculum, but also teaches daily religion classes, is a commissioned minister, and regularly leads students in prayer and worship.Certiorari stage documents:Opinion below (6th Circuit)Petition for certiorariBrief in… [read post]
24 Mar 2011, 12:53 pm
Rodriguez Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
28 Dec 2010, 10:58 am
Caraco Pharmaceutical Laboratories, Ltd., 601 F.3d 1359 (Fed. [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
8 Dec 2010, 2:20 am
(America-Israel Patent Law) Ziagen (Abacavir) – US: Mylan’s Matrix receives tentative FDA approval under PEPFAR for Abacavir Sulfate tablets, 60 mg (SmartBrief) [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
28 Sep 2010, 3:14 pm
Roche Holding Ltd. et al. [read post]
